Kezar Life Sciences, Inc. (KZR)
NASDAQ: KZR · Real-Time Price · USD
6.27
-0.04 (-0.63%)
Oct 21, 2025, 2:55 PM EDT - Market open
Kezar Life Sciences Stock Forecast
Stock Price Forecast
The 2 analysts that cover Kezar Life Sciences stock have a consensus rating of "Hold" and an average price target of $6.00, which forecasts a -4.31% decrease in the stock price over the next year. The lowest target is $5.00 and the highest is $7.00.
Price Target: $6.00 (-4.31%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Kezar Life Sciences stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
Rating | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 |
---|---|---|---|---|---|---|
Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Hold | 2 | 2 | 2 | 2 | 2 | 4 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 2 | 2 | 2 | 2 | 2 | 4 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Jefferies | Jefferies | Strong Buy → Hold Downgrades $18 → $7 | Strong Buy → Hold | Downgrades | $18 → $7 | +11.64% | Oct 17, 2025 |
William Blair | William Blair | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Oct 17, 2025 |
Wells Fargo | Wells Fargo | Hold Maintains $7 → $5 | Hold | Maintains | $7 → $5 | -20.26% | Oct 17, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Jul 16, 2025 |
Wells Fargo | Wells Fargo | Hold Maintains $11 → $9 | Hold | Maintains | $11 → $9 | +43.54% | Dec 19, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-8.54
from -11.49
EPS Next Year
-6.27
from -8.54
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | n/a | n/a | |||
Avg | n/a | n/a | |||
Low | n/a | n/a |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | - | - | |||
Avg | - | - | |||
Low | - | - |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | -6.84 | -4.63 | |||
Avg | -8.54 | -6.27 | |||
Low | -10.12 | -7.74 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | - | - | |||
Avg | - | - | |||
Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.